#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Cognitive disorder Palmoplantar pustulosis Pouchitis Factor VIII deficiency Malignant central nervous system neoplasm Essential thrombocythaemia Skin angiosarcoma Hypoxic-ischaemic encephalopathy Neuroendocrine carcinoma of the skin Fontan procedure Chronic lymphocytic leukaemia refractory Adrenogenital syndrome Lymphoma Malignant glioma Metastases to central nervous system More trials…
Learn about Rare Diseases

Loeys-Dietz syndrome – Treatment Methylmalonic acidaemia – Life with Disease Crigler-Najjar syndrome – Trials in Disease Urea cycle disorder Pulmonary fibrosis – Treatment Leiomyosarcoma – Treatment Marginal zone lymphoma – Treatment Fabry’s disease – Life with Disease Gastrointestinal stromal tumour – Trials in Disease Congenital generalised lipodystrophy – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Pirfenidone Zinc Acetate Dihydrate Absk021 Hydrochloride Hydrate Satralizumab Teprenone Berubicin Hydrochloride Carbamazepine Ab-729 Soya-Bean Oil Refined Exl01 Tasimelteon Ivonescimab RP2 Spironolactone Psilocybine Avacopan Dexlansoprazole Tomligisiran Pimecrolimus Dulaglutide More therapies…

Learn about Your Condition

Organ donor Procedural pain Cold urticaria Infection Hypomagnesaemia K-ras gene mutation Cystic fibrosis Rectal cancer stage II Neuroblastoma recurrent Spinal cord injury Metastatic glioma Chronic kidney disease Eye inflammation Atopic keratoconjunctivitis Factor IX deficiency More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Peyronie’s disease

Study on the Safety and Effectiveness of Vibrio Alginolyticus Collagenase and Alprostadil for Patients with Peyronie’s Disease

Recruiting

1 1 1 1
Investigated Diseases:
- Peyronie’s disease
Investigated Drugs:
- ALPROSTADIL
- Vibrio Alginolyticus Collagenase
Study on the Use of FAPI-PET/CT and FDG-PET/CT Scans for Detecting Active Fibroblasts and Inflammation in Patients with Acute Phase Peyronie’s Disease

Recruiting

3 1 1
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Peyronie’s disease

Study on the Safety and Effectiveness of Vibrio Alginolyticus Collagenase and Alprostadil for Patients with Peyronie’s Disease

Study on the Use of FAPI-PET/CT and FDG-PET/CT Scans for Detecting Active Fibroblasts and Inflammation in Patients with Acute Phase Peyronie’s Disease

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies